Machado Meyer Advogados acted as legal counsel to Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, in the acquisition of equity interest representing 100% of the capital stock of Libber Pharma Importação e Distribuição de Medicamentos, currently held by the founding equityholders.

To read the full story click here.

(The Latin American Lawyer - 01.06.2023)